[Hormone kinetics in suppression with monthly Enantone depot preparations].
Schilling
A
A
D000970:Antineoplastic Agents; D003692:Delayed-Action Preparations; D004334:Drug Administration Schedule; D006801:Humans; D007279:Injections, Subcutaneous; D016729:Leuprolide / Q000008:administration & dosage*; D008297:Male; D009376:Neoplasms, Hormone-Dependent / Q000097:blood / Q000628:therapy*; D011471:Prostatic Neoplasms / Q000097:blood / Q000628:therapy*; D013739:Testosterone / Q000097:blood*
D000970:Antineoplastic Agents; D003692:Delayed-Action Preparations; D013739:Testosterone; D016729:Leuprolide
Hormonkinetik bei Suppression mit Enantone Monats-Depot.